Abstract Form

Title: Ahmed Glaucoma Valve Implantation For Refractory Glaucoma In Tertiary Hospital in Iran: a 5 Years study
Author(s): NaveedNilforushan1 MD, Arezoo Miragtabi1 MD, Maryam Yadgari1 MD,Sayyed Amirpooya Alemzadeh M.D1
Presentation Type: Oral
Subject: Glaucoma
Others:
Presenting Author:
Name: Naveed Nilforushan
Affiliation :(optional) Eye research center, Rassoul Akram Hospital,Iran University of Medical Sciences, Tehran, Iran
E mail: naveednil@yahoo.com
Phone: 88032410
Mobile: 09123576823
Abstract (Max 200 words)
Purpose: To evaluate the success rate and complications ofAhmed Glaucoma Valve(AGV) insertionduring a follow up of at least 5 years.
Methods: In this retrospective case series study, patients with 5 years of follow up after Ahmed Glaucoma Valve insertion were enrolled. Exclusion criteria were incomplete postoperative medical recordsand ocular surgeries other than glaucoma surgery in the follow up period. Success was defined as IOP < 21 mm Hg (criterion A) and IOP < 16 mm Hg (criterion B), with at least 20% reduction in IOP, either with no medication (complete success) or with no more than 2 medications (qualified success). Cumulative success was defined as sum of qualified and complete success.
Results: This study included 40 eyes of 40 patients withmean age of 40.63± 22.91years, (range 1 to 88). cumulative surviaval success rates of 90% , 73% at 1 and 5 years according to criterion A and 42% ,25% based on criterion B with the median survival time of 60 months and 22.36 months respectively.
Conclusion: The wide difference of success rate between criterion A and B in this study suggest more emphasize on considering lower IOP as cut off for success description.
Attachment: 1021AGV slides.pptx